Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human BTRC Antibodies:
anti-Rat (Rattus) BTRC Antibodies:
anti-Mouse (Murine) BTRC Antibodies:
Go to our pre-filtered search.
Strong ERK (show MAPK1 Antibodies) activation can target Cdc25A (show CDC25A Antibodies) for degradation in a manner similar to, but independent of, Chk1 (show CHEK1 Antibodies) for cell cycle arrest.
It demonstrates that degradation of Lipin-1 (show LPIN1 Antibodies) is regulated by BTRC in the cytoplasm and on membranes
we identified two independent SNPs (i.e., WNT2B (show WNT2B Antibodies) rs1175649 G>T and BTRC rs61873997 G>A) that showed a predictive role in CM-specific survival, with an effect-allele-attributed hazards ratio (adjusted hazards ratio) of 1.99 (95% confidence interval = 1.41-2.81, P = 8.10 x 10(-5)) and 0.61 (0.46-0.80, 3.12x10(-4)), respectively.
It has been proposed that CENP-W (show CENPW Antibodies) may function as a booster of beta-TrCP1 nuclear import to increase the oncogenicity of beta-TrCP1.
oncogenic effect of miR (show MLXIP Antibodies)-182 and its reversal by beta-TrCP2 were confirmed in vivo This study suggests that beta-TrCP and miR (show MLXIP Antibodies)-182 may be possible biomarkers and targets for early detection and treatment of pancreatic cancer
Beta-TrCP controls ubiquitination and degradation of liver-enriched transcription factor CREB-H (show CREB3L3 Antibodies).
Phosphorylated VEGFR-2 (show KDR Antibodies) was reduced by hyperglycemia while total VEGFR-2 (show KDR Antibodies) was almost unaltered. However, VEGFR-2 (show KDR Antibodies) was reduced when directly exposed to reactive oxygen species, with resultant co-location of beta-TrCP and VEGFR-2 (show KDR Antibodies).
Low GAS7C increases cancer cell motility by promoting N-WASP (show WASL Antibodies)/FAK (show PTK2 Antibodies)/F-actin cytoskeleton dynamics. It also enhances beta-catenin (show CTNNB1 Antibodies) stability via hnRNP U (show HNRNPU Antibodies)/beta-TrCP complex formation.
EBV-miR (show MLXIP Antibodies)-BART10-3p facilitated epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
beta-TrCP1/FWD1 dominant negative mutant has a role in reducing myeloma cell growth
This study showed SCF (show KITLG Antibodies)(beta-TRCP) earmarks Set8 (show SETD8 Antibodies) for ubiquitination and degradation in a casein kinase I (show CSNK1D Antibodies)-dependent manner, which is activated by DNA-damaging agents.
betaTrCP levels are correlated with imiquimod-induced skin lesion.
Erbin (show ERBB2IP Antibodies) as a novel substrate of SAG (show RNF7 Antibodies)-betaTrCP E3 ligase.
these results clearly suggest that both beta-TrCP- and Hrd1 (show SYVN1 Antibodies)-dependent degradation mechanisms regulate the transcriptional activity of Nrf1 (show NRF1 Antibodies) to maintain cellular homeostasis.
beta-TrCP may be an essential player in UVB induced responses in skin
Glycogen synthase kinase 3 (show GSK3a Antibodies) phosphorylates a group of Ser (show SIGLEC1 Antibodies) residues in the Neh6 domain of mouse Nrf2 (show NFE2L2 Antibodies) that overlap with an SCF (show KITLG Antibodies)/beta-TrCP destruction motif (DSGIS, residues 334 to 338) and promotes its degradation in a Keap1 (show KEAP1 Antibodies)-independent manner.
LPS (show TLR4 Antibodies) appears to destabilize the LPCAT1 (show LPCAT1 Antibodies) protein by GSK-3beta (show GSK3b Antibodies)-mediated phosphorylation within a canonical phosphodegron for beta-TrCP docking and site-specific ubiquitination.
the two beta-TrCP paralogs have a nonredundant role in spermatogenesis
anti-inflammatory effects of H(2)O(2) may result from its ability to decrease ubiquitination as well as subsequent degradation of I kappaB alpha through inhibiting the association between I kappaB alpha and SCF (show KITLG Antibodies)(beta-TrCP)
BMP-2 (show BMP2 Antibodies) modulates beta-catenin (show CTNNB1 Antibodies) signaling through stimulation of Lrp5 (show LRP5 Antibodies) expression and inhibition of beta-TrCP expression in osteoblasts
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbws class\; in addition to an F-box, this protein contains multiple WD-40 repeats. The encoded protein mediates degradation of CD4 via its interaction with HIV-1 Vpu. It has also been shown to ubiquitinate phosphorylated NFKBIA (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha), targeting it for degradation and thus activating nuclear factor kappa-B. Alternatively spliced transcript variants have been described. A related pseudogene exists in chromosome 6.
beta-transducin repeat containing
, beta-transducin repeat containing protein
, F-box/WD repeat-containing protein 1A
, f-box/WD repeat-containing protein 1A-like
, F-box and WD repeats protein beta-TrCP
, F-box and WD-repeat protein 1B
, epididymis tissue protein Li 2a
, pIkappaBalpha-E3 receptor subunit
, beta-transducin repeat-containing protein
, SCF b-TRCP
, beta-TrCP protein E3RS-IkappaB
, pIkappaB-E3 receptor subunit
, ubiquitin ligase FWD1